Hennepin Life Sciences

Description

• Hennepin Life Sciences is a growth stage human and animal health company that is uniquely focused on the development of patent protected, novel, naturally-derived anti-infective compounds for the prevention and treatment of a wide array of infections. We created innovative nature-based therapies by combining molecular concepts of infection to clinical applications. Founded in 2009 from a technology transfer out of the University of Minnesota, Hennepin Life Sciences (HLS) is a Phase2 clinical trial stage, Minnesota -based biotechnology firm that continues to develop a patented approach to address the global super bug challenge. Today, HLS continues to expand its product platform intellectual property, advance the practical science through clinical studies and is active forging distribution partnerships to initially reach clinical application. Not only is the spectrum solution highly relevant for the super bug era we live in, it has broad applicability in the human and animal health markets. Studies thus far have shown the Hennepin Life Sciences (HLS) approach to safely kill bacteria, fungus and viruses while nearly eliminating bacterial mutations. This is subsequently why HLS is confident in eventually pursuing both broad markets such as highly scrutinized hospital acquired infection (HAI) market and the more defined and rapidly growing women's health category being shaped by millennial expectations.
• 

  Headquarters:Po Box 47502 , Plymouth, Minnesota, United States

  More
• 

  Phone Number: +1 763-923-5365

• 

  Website: https://www.hennepinlifesciences.com

• 

  Employees:4

• 

  Revenue:$1 - 10M

• 

  Legal Name:Hennepin Life Sciences

• Hennepin Life Sciences's Social Media

  
• Is this data correct?

• |  NAICS Code: 423460  |

  Show More